Magle Chemoswed AB

Magle Chemoswed AB manufactures medical devices such as the SmartPAN system and the Embocept S DSM 50 µm embolic device. These products are designed for specific clinical applications, with SmartPAN serving as a specialized surgical tool and Embocept S DSM 50 µm providing a controlled embolization solution. The company’s portfolio includes these two example devices as stated in the provided data.

Magle Chemoswed AB is headquartered in Sweden, as indicated by the country code SE in the device data. The company’s location is explicitly stated in the summary section, confirming its base of operations is in Sweden.

The devices manufactured by Magle Chemoswed AB are listed in the Eudamed database, which is the European Union’s medical device registry. This is explicitly stated in both the DEVICE_DATA section under 'LISTED IN' and in the summary, confirming Eudamed as the registry where the company’s devices are recorded.

The devices manufactured by Magle Chemoswed AB are classified as Class IIa and Class IIb under the European Union’s medical device classification system. This classification is directly stated in the DEVICE_DATA section and reiterated in the summary, indicating the risk-based regulatory category for their products.